Principal Investigator: Olga Gyrina.
Trial type(s): Medical devices, Medicines, Tissues or Cell transplants.
Trial phase(s): Phase II, Phase III, Phase IV.
Medical area(s): Cardiology, Dermatology, Endocrinology, Gastroenterology, Gerontology, Hematology, Hepatology, Immunology, Internal Medicine, Mammology, Nephrology, Neurology, Ophthalmology, Otorhinolaryngology, Pulmonology, Rheumatology, Stain Cells Treatment, Stomatology, Urology, Vascular Surgery.
Disease(s): Anemia, Angina, Ankylosing Spondylitis, Arrhythmia, Artetial Hypertension, Asthenia, Asthma, Atherosclerosis, Atopic Dermatitis, Atrial Fibrillation, BPH, Chronic Kidney Disease, Congestive Heart Failure, Coronary Artery Disease, Crohn’s Disease, Deep Vein Thrombosis, Dermatitis, Diabetic Nephropathy, DM type 1, DM type 2, Hepatitis, Hyperactive bladder, Influenza, Irritable bowel syndrome, Multiple Sclerosis, Osteoarthritis, Osteoporosis, Pain, Parkinson’s disease, Pneumonia, Psoriasis, Rheumatoid Arthritis, Skin infections, Thyroid Diseases, Ulcerative Colitis.
Trial experience (full years): 22.
Clinical base (Hospital or Institution with beds): Limited Liability Company Treatment and Diagnostic Center ADONIS Plus, Outpatient Department.
Department(s) of Clinical base: Outpatient Department.
Address info
Contact person: Sergii Skupyi.
Address of Clinical base: 02002 Ukraine, Kyivska Oblast, Kyiv, 8b, Raisy Okipnoi St., Kyiv, 02002, Ukraine.
Tel.: +380673076714, +380953940214.
Fax: +38044 517 07 27.
E-mail: study.adonis@gmail.com.